We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+12.34%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$29.4M
Cap. Flow
+$7.16M
Cap. Flow %
3.23%
Top 10 Hldgs %
18.89%
Holding
825
New
141
Increased
191
Reduced
199
Closed
29

Top Buys

Rank Stock Value
1
VGLT icon
Vanguard Long-Term Treasury ETF
VGLT
+$3.45M
2
MMM icon
3M
MMM
+$407K
3
TEX icon
Terex
TEX
+$363K
4
SNA icon
Snap-on
SNA
+$359K
5
HTGC icon
Hercules Capital
HTGC
+$313K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$820K
2
WPC icon
W.P. Carey
WPC
+$620K
3
CAH icon
Cardinal Health
CAH
+$537K
4
AVGO icon
Broadcom
AVGO
+$533K
5
IRM icon
Iron Mountain
IRM
+$488K

Sector Composition

Rank Sector Weight
1 Technology 25.31%
2 Real Estate 17.37%
3 Industrials 12.34%
4 Healthcare 7.99%
5 Consumer Discretionary 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AI icon
551
C3.ai
AI
$1.62B
$7.03K ﹤0.01%
245
– –
REGN icon
552
Regeneron Pharmaceuticals
REGN
$83.2B
$7.03K ﹤0.01%
8
– –
FOXA icon
553
Fox Class A
FOXA
$26.6B
$6.98K ﹤0.01%
235
– –
PLX icon
554
Protalix BioTherapeutics
PLX
$200M
$6.91K ﹤0.01%
3,880
– –
PBA icon
555
Pembina Pipeline
PBA
$27.8B
$6.88K ﹤0.01%
200
+100
+100% +$3.2K
PDSB icon
556
PDS Biotechnology
PDSB
$40.9M
$6.82K ﹤0.01%
1,372
– –
ENB icon
557
Enbridge
ENB
$112B
$6.81K ﹤0.01%
189
– –
EXAS
558
DELISTED
Exact Sciences
EXAS
$6.73K ﹤0.01%
91
– –
XLB icon
559
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$6.69K ﹤0.01%
+156
New +$6.24K
AZN icon
560
AstraZeneca
AZN
$251B
$6.6K ﹤0.01%
49
– –
CPRX
561
DELISTED
Catalyst Pharmaceutical
CPRX
$6.57K ﹤0.01%
391
– –
IHF icon
562
iShares US Healthcare Providers ETF
IHF
$1.27B
$6.56K ﹤0.01%
125
– –
INDI icon
563
indie Semiconductor
INDI
$786M
$6.49K ﹤0.01%
800
+100
+14% +$652
IEF icon
564
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$6.46K ﹤0.01%
+67
New +$6.2K
GOF icon
565
Guggenheim Strategic Opportunities Fund
GOF
$2.26B
$6.4K ﹤0.01%
+500
New +$6.52K
XPO icon
566
XPO
XPO
$23.5B
$6.39K ﹤0.01%
73
– –
ITCI
567
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.37K ﹤0.01%
89
– –
ACAD icon
568
Acadia Pharmaceuticals
ACAD
$5.06B
$6.23K ﹤0.01%
199
– –
OPI
569
DELISTED
Office Properties Income Trust
OPI
$6.22K ﹤0.01%
+850
New +$4.52K
AUPH icon
570
Aurinia Pharmaceuticals
AUPH
$2.06B
$6.18K ﹤0.01%
687
– –
DYN icon
571
Dyne Therapeutics
DYN
$4.95B
$6.17K ﹤0.01%
464
– –
TEI
572
Templeton Emerging Markets Income Fund
TEI
$322M
$6.12K ﹤0.01%
+1,200
New +$5.76K
BDX icon
573
Becton Dickinson
BDX
$48.9B
$6.1K ﹤0.01%
25
– –
IAE
574
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$92.9M
$6.01K ﹤0.01%
+1,000
New +$5.71K
EYPT icon
575
EyePoint Inc
EYPT
$1.13B
$5.96K ﹤0.01%
258
– –
21 22
23
24 25

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Truvestments Capital held 825 positions worth $221M, up 15% from $192M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital deployed $7.16M of net new capital in Q4 2023, opening 141 new positions and adding to 191 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 61,107 shares worth $3.76M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was Intel, an estimated $820K trimmed.

  • Truvestments Capital's largest Q4 2023 buy was Vanguard Long-Term Treasury ETF: 61,107 shares worth $3.76M.
  • Truvestments Capital added most to 3M in Q4 2023, an estimated $407K increase.
  • Truvestments Capital's biggest Q4 2023 reduction was Intel, cutting an estimated $820K.
  • Truvestments Capital fully exited VMware, Inc in Q4 2023, selling an estimated $160K.
  • Truvestments Capital's ten largest holdings make up 19% of its $221M portfolio in Q4 2023.
  • Truvestments Capital opened 141 new positions and closed 29 in Q4 2023.
  • Truvestments Capital's portfolio value rose 15% quarter-over-quarter to $221M.

Based on Truvestments Capital's 13F filing for Q4 2023, filed 14 Feb 2024.